The prevalence of childhood atopic diseases has increased during the last 30 years (1) . Epidemiological studies have linked higher fish intake during pregnancy with lower risk of atopy in the offspring (2) . Furthermore, fish oil supplementation during pregnancy alters maternal and offspring immunity in a way that would be consistent with lowered risk of atopy (3) . Fish provide not only long chain (LC) n-3 polyunsaturated fatty acids (PUFAs) (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) found in fish oils but also other nutrients. There are no studies of oily fish intervention in pregnancy and maternal immunity or infant atopy. The hypotheses examined by the work described here are that increased salmon consumption during pregnancy by women with high risk of having an atopic offspring will increase maternal peripheral blood mononuclear cell (PBMC) LC n-3 PUFA status and alter PBMC cytokine responses, which may potentially influence the developing foetal immune system in a way that would decrease atopy risk for the offspring.
